Atlas Trials

Safety and Tolerability of WVE-210201 in Patients With Duchenne Muscular Dystrophy

Clinical trial NCT03508947 · COMPLETED

Trial details

NCT number
NCT03508947
Sponsor
Wave Life Sciences USA, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Duchenne Muscular Dystrophy
Start date
2018-01-24
Primary completion
2019-03-06
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.